Chemotherapy use, end-of-life care, and costs of care among patients diagnosed with Stage IV pancreatic cancer
For patients with metastatic cancer and limited life-expectancy, potential benefits of chemotherapy must be balanced against harms to quality-of-life near death and increased out-of-pocket costs of care.
Source: Journal of Pain and Symptom Management - Category: Palliative Care Authors: Yuhua Bao, Renee C. Maciejewski, Melissa M. Garrido, Manish A. Shah, Paul K. Maciejewski, Holly G. Prigerson Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Pain | Pain Management | Palliative Care | Pancreas | Pancreatic Cancer